Ximelagatran/melagatran against conventional anticoagulation: A meta-analysis based on 22,639 patients
- 15 January 2007
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 122 (2), 117-124
- https://doi.org/10.1016/j.ijcard.2006.11.041
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- New Anticoagulants: Anti IIa vs Anti Xa—Is One Better?Journal of Thrombosis and Thrombolysis, 2006
- Direct Thrombin InhibitorsNew England Journal of Medicine, 2005
- A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trialsInternational Journal of Epidemiology, 2004
- The safety of antithrombotic therapy during pregnancyExpert Opinion on Drug Safety, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- American Heart Association/American College of Cardiology Foundation Guide to Warfarin TherapyCirculation, 2003
- Comparison of the Oral Direct Thrombin Inhibitor Ximelagatran With Enoxaparin as Prophylaxis Against Venous Thromboembolism After Total Knee ReplacementArchives of Internal Medicine, 2001
- Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statementThe Lancet, 1999
- Oral AnticoagulantsChest, 1998
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997